医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Canon Medical to Launch New Division in Dubai, UAE

2019年10月14日 PM02:00
このエントリーをはてなブックマークに追加


 

OHTAWARA, Japan

Canon Medical Systems Corporation is pleased to announce the official opening of its Middle East Division in Canon Middle East Dubai, UAE. Preparations are now underway to start business operations around the beginning of January 2020. (visit the Canon Medical website : https://global.medical.canon/MEA/index.html )

After more than thirty years of experience in the Middle East market, Canon Medical is committed to delivering the best possible service to its customers and partners in the region.

Toshio Takiguchi, President and CEO, Canon Medical, said: “Establishing a Canon Medical Division in the Middle East is an integral part of our strategy to get closer to our customers through direct presence in key regional markets. Through our products and business solutions, Canon Medical aims to help customers in the region address new opportunities and develop their business.”

Canon will continue its efforts to contribute to the development of healthcare and to help people everywhere enjoy a healthy life.

About Canon Medical Systems Corporation
Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound and MR, across the globe. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.

For more information, visit the Canon Medical website: https://global.medical.canon

Aplio, Aquilion, Aquilion ONE, Alphenix , Made for Life are trademarks of Canon Medical Systems.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191013005008/en/

CONTACT

Canon Medical Systems Corporation

Masami Tanaka

Middle East & Africa Group

International Sales Division

+81(03) 6369 9669

masami3.tanaka@medical.canon

同じカテゴリーの記事 

  • Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)
  • Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
  • Inocras Hong Kong Limited, in Collaboration with Cancerinformation.com.hk Charity Foundation and Sponsored by AstraZeneca Hong Kong, Offers Free BRCA or HRD Genetic Testing for Eligible Cancer Patients in Hong Kong and Macau
  • BrainChip Earns Australian Patent for Improved Spiking Neural Network
  • Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies